Actively Recruiting
Study of HLA-DRB1*0401 Gene in Adults Aged 18 to 55 Recently Diagnosed With Type 1 Diabetes
Led by GentiBio, Inc · Updated on 2026-08-11
200
Participants Needed
5
Research Sites
4 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the distribution of the HLA-DRB1*0401 genotype in adults recently diagnosed with type 1 diabetes, within 6 months of diagnosis. This observational study aims to better understand the genetic profile of these participants to inform future research. The study is conducted by GentiBio, Inc. and involves adults aged 18 to 55 years with confirmed type 1 diabetes. Participants will have a single blood draw or may choose to provide cheek swabs for analysis of the HLA-DRB1*0401 genotype and other HLA alleles. This non-interventional study involves only one visit, during which demographic information and biological samples will be collected. There are no treatments or medications administered as part of this research. During the study visit, participants provide demographic data and a blood or cheek swab sample for genetic testing. A follow-up phone call is conducted about 24 hours later to complete data collection. Researchers will measure the presence of the HLA-DRB1*0401 genotype and analyze its distribution across ethnic and racial subgroups. The total participation time is approximately 24 hours from visit to follow-up call.
CONDITIONS
Brief Title
HLA Demographics Study in Adults With Type 1 Diabetes
Research Team
K
Kristin M Neff, MS
M
Mark Bach, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
